AG-013736 In Combination With Docetaxel Versus Docetaxel Alone For Patients With Metastatic Breast Cancer

NCT00076024 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Placebo
DRUG: Docetaxel
DRUG: AG-013736 (axitinib)
DRUG: Docetaxel

Sponsor

Pfizer